dioxacarb: structure
ID Source | ID |
---|---|
PubMed CID | 23421 |
CHEMBL ID | 3188645 |
CHEBI ID | 82093 |
SCHEMBL ID | 119641 |
MeSH ID | M0062163 |
Synonym |
---|
carbamic acid, methyl-, o-(1,3-dioxolan-2-yl)phenyl ester |
phenol, 2-(1,3-dioxolan-2-yl)-, methylcarbamate |
elocron 8353 |
2-(1,3-dioxolan-2-yl)phenyl-n-methylcarbamat [german] |
dioxacarb [ansi:bsi:iso] |
mcdp |
c 8353 |
ai3-27389 |
ent 27,389 |
caswell no. 393a |
einecs 230-253-4 |
dioxacarb |
elocron |
epa pesticide chemical code 392100 |
du pont insecticide 1519 |
ciba c 8353 |
c-8353 , |
dioxokarb [polish] |
carbamic acid, methyl-, o-1,3-dioxolan-2-ylphenyl ester |
ciba 8353 |
famid |
rovlinka |
nsc 190981 |
elocron 50wp |
brn 1348191 |
dioxacarbe |
2-(1,3-dioxolan-2-yl)phenol methylcarbamate |
o-(1,3-dioxolan-2-yl)phenyl methylcarbamate |
dioxacarbe [iso-french] |
du pont 1519 |
dioxocarb |
2-(1,3-dioxolan-2-yl)phenyl methylcarbamate |
[2-(1,3-dioxolan-2-yl)phenyl] n-methylcarbamate |
C18953 |
6988-21-2 |
dtxcid0021886 |
NCGC00255496-01 |
cas-6988-21-2 |
tox21_302420 |
dtxsid2041886 , |
2-(1,3-dioxolan-2-yl)phenyl-n-methylcarbamat |
698bek3133 , |
5-19-02-00547 (beilstein handbook reference) |
unii-698bek3133 |
dioxokarb |
AKOS015902513 |
dioxacarb [iso] |
phenol, 2-(1,3-dioxolan-2-yl)-, 1-(n-methylcarbamate) |
2-(1,3-dioxolane-2-yl)-phenyl n-methylcarbamate |
2-(1,3-dioxolan-2-yl)phenyl n-methylcarbamate |
du pont-1519 |
elocron-8353 |
SCHEMBL119641 |
CHEBI:82093 , |
2-(1,3-dioxolan-2-yl)phenyl methylcarbamate # |
elecron 50 |
2-(1,3-dioxolane-2-yl)phenyl n-methylcarbamate |
CHEMBL3188645 |
pesticide3_dioxacarb_c11h13no4_phenol, 2-(1,3-dioxolan-2-yl)-, methylcarbamate |
FT-0667620 |
Q22807435 |
o-(1,3-dioxalan-2-yl)phenyl methylcarbamate |
Class | Description |
---|---|
benzenes | Any benzenoid aromatic compound consisting of the benzene skeleton and its substituted derivatives. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 0.5421 | 0.0060 | 38.0041 | 19,952.5996 | AID1159521 |
AR protein | Homo sapiens (human) | Potency | 46.6943 | 0.0002 | 21.2231 | 8,912.5098 | AID743035; AID743036 |
aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 59.1188 | 0.0007 | 23.0674 | 1,258.9301 | AID743085; AID743122 |
heat shock protein beta-1 | Homo sapiens (human) | Potency | 21.7681 | 0.0420 | 27.3789 | 61.6448 | AID743210 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (23.88) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |